Ranked in 2 industries
This company is listed under more than one industry, so we show its position in each rather than picking one.
The average time taken for BOSTON SCIENTIFIC LIMITED to pay invoices has remained relatively consistent over the past three periods, ranging from 38 to 41 days. However, there was a slight increase in the most recent period, going from 38 to 41 days.
The data for BOSTON SCIENTIFIC LIMITED shows very little volatility, with the percentage of invoices paid within 30 days, between 31 and 60 days, and later than 60 days remaining relatively consistent over the past three periods. The only noticeable change is in the percentage of invoices paid within 30 days, which saw a decrease from 33% to 16% in the most recent period.
In the past three periods, BOSTON SCIENTIFIC LIMITED has maintained an average time of 38-41 days to pay invoices. The company has consistently paid around 80% of their invoices within 60 days, with a small decrease in the most recent period to 72%. However, the percentage of invoices paid within 30 days has seen a significant decrease from 33% to 16% in the most recent period.
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2021 - 31 Dec 2021 | 27 Apr 2022 | 41 | 16% | 83% | 1% | 2% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Oct 2021 | 40 | 17% | 82% | 1% | 1% |
| 01 Jul 2020 - 31 Dec 2020 | 26 Mar 2021 | 39 | 19% | 80% | 1% | 1% |
| 01 Jan 2020 - 30 Jun 2020 | 13 Aug 2020 | 38 | 27% | 72% | 1% | 1% |
| 01 Jul 2019 - 31 Dec 2019 | 13 Feb 2020 | 40 | 13% | 87% | 0% | 1% |
| 01 Jan 2019 - 30 Jun 2019 | 05 Aug 2019 | 47 | 33% | 67% | 0% | 1% |
| 01 Jul 2018 - 31 Dec 2018 | 01 Feb 2019 | 38 | 21% | 79% | 0% | 1% |
| 01 Jan 2018 - 30 Jun 2018 | 30 Jul 2018 | 38 | 26% | 74% | 0% | 1% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
Our standard payment terms are between 30 and 45 days net after receipt of a correct invoice and Products or Services.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
60
We aim to resolve disputes and answer queries as quickly as possible. Disputes and questions on invoices and payments are handled by our Accounts Payable team, who can be contacted on PTPGreatBritain@bsci.com. Please be prepared with your invoice number, PO number if applicable and other details related to the invoice.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Boston Scientific Limited is the UK entity of the global Boston Scientific group, a manufacturer of medical devices used across specialties including cardiology, urology, gastroenterology and neurology. Companies House records list its activities as wholesale of machinery and equipment and other human health activities, consistent with a role supplying and supporting the group's medical technology products within the UK market. The wider Boston Scientific group, headquartered in the US, describes itself as dedicated to transforming lives through innovative medical solutions that improve patient health worldwide. The UK company is registered in Hemel Hempstead and remains active, operating as part of this international medical device business rather than as an independent manufacturer in its own right.
Generated from the company's website and Companies House records. Sources: bostonscientific.com